Trenzyme GMBH
Konstanz, BW
- UEI
- N7BSALPEB263
- CAGE
- CC377
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- Byk-Gulden-Straße 2, 78467 Konstanz, Germany
- Website
- trenzyme.com
- Founded
- 2000
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| PCR-amplification and cloning of TET-on inducible exoin-c/E3/E2/6K/E1 vector | NIAID DEA OA Acquisitions (NIH) | $103,509 |
Quick answers
Is Trenzyme GMBH registered in SAM.gov?
Yes. Trenzyme GMBH's SAM.gov registration is active through October 8, 2027.
What is Trenzyme GMBH's most recent federal award?
Trenzyme GMBH's most recent federal contract award is PCR-amplification and cloning of TET-on inducible exoin-c/E3/E2/6K/E1 vector (HHSN272200900622P), from NIAID DEA OA Acquisitions (NIH), on July 9, 2009.
On GovTribe
See Trenzyme GMBH's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors